Innocan Pharma Corp. Stock
€4.00
Your prediction
Innocan Pharma Corp. Stock
Pros and Cons of Innocan Pharma Corp. in the next few years
Pros
Cons
News
Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
Herzliya, Israel and Calgary, Alberta – February 09, 2026 – Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
Herzliya, Israel and Calgary, AB – January 27, 2026 – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
Herzliya, Israel and Calgary, AB – 2 January 2026– Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing

